Journal of Diabetes & Metabolism

ISSN - 2155-6156

Randomized controlled clinical trial open to 24 weeks of efficiency and safety in outpatient with obesity grade. and II treated with clobenzorex vs clobenzorex with melatonin

15th Global Diabetes & Obesity Conference

November 14-15, 2016 Dubai, UAE

Pamela Georgina Avila Lamadrid

Superior School of Medicine at Instituto Politecnico Nacional, Mexico

Posters & Accepted Abstracts: J Diabetes Metab

Abstract :

Obesity is disease characterized by the excess of adiposite tissue (fat) in the body. Such disease is determined when in an adult persons there is Body Mass Index (BMI by the acronym in English) is equal or higher than 30 kg/m2. Purpose: To evaluate the efficacy and safety of Clobenzorex 60 mg/ Melatonin 3mg (morning or night) against to Clobenzorex 60 mg in Mexicans with exogenous obesity during 24 weeks. It was. longitudinal, prospective and comparative study. This study was conducted under 180 exogenous obese patients, to which was administered: (i) Treatment ??A? (Clobenzorex 60 mg/ Melatonin 3mg. capsule VO, morning), (ii) Treatment ??B? (Clobenzorex 60 mg. capsule VO Melatonin 3mg one night); or (iii) Treatment ??C? (60 mg. capsule Clobenzorex VO, am). Efficacy was evaluated by (i) weight loss (kg); (ii) BMI; (iii) Waist-to-Hip Ratio (WHR by the acronym in English); and (iv) percentage of body fat. In the other hand safety was evaluated by recording adverse events occurred.

Biography :

Email: pamghy@hotmail.com

Top